Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MediWound (MDWD) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for MediWound (MDWD) over the last 13 years, with Q3 2025 value amounting to $4.5 million.

  • MediWound's Cost of Revenue rose 2324.63% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.1 million, marking a year-over-year decrease of 125.65%. This contributed to the annual value of $17.6 million for FY2024, which is 1641.51% up from last year.
  • Per MediWound's latest filing, its Cost of Revenue stood at $4.5 million for Q3 2025, which was up 2324.63% from $4.4 million recorded in Q2 2025.
  • In the past 5 years, MediWound's Cost of Revenue registered a high of $4.9 million during Q4 2024, and its lowest value of $2.9 million during Q1 2022.
  • Moreover, its 5-year median value for Cost of Revenue was $3.7 million (2021), whereas its average is $3.8 million.
  • Its Cost of Revenue has fluctuated over the past 5 years, first soared by 4655.23% in 2024, then crashed by 2616.48% in 2025.
  • MediWound's Cost of Revenue (Quarter) stood at $3.9 million in 2021, then fell by 12.36% to $3.5 million in 2022, then surged by 33.5% to $4.6 million in 2023, then grew by 6.88% to $4.9 million in 2024, then decreased by 8.18% to $4.5 million in 2025.
  • Its Cost of Revenue stands at $4.5 million for Q3 2025, versus $4.4 million for Q2 2025 and $3.2 million for Q1 2025.